Top Markets
Coin of the day
Viropro Inc. Viropro Inc.

Viropro Inc.

VPRO
株式のランク #41344
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract... Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeutic proteins through the licensing of its proprietary technologies, targeting illnesses like cancer, diabetes, hepatitis, and multiple sclerosis. Viropro manufactures a range of biologics drugs, including biosimilars, for use across all phases of clinical development, from pre-clinical studies through Phase I, II, and III trials. Its offerings to clients include the provision of mammalian cell proteins, such as monoclonal antibodies, recombinant proteins, and other cell-derived compounds. Notably, the firm owns three proprietary clones: two intended for insulin-related therapies and one for cancer treatment. Viropro delivers extensive contractual research and manufacturing solutions to biotech and biopharmaceutical enterprises, performing tasks such as cloning, sequencing, purification, development, validation, and production of biopharmaceutical components and finished products. The company maintains operational presences in Canada, the United Kingdom, and Malaysia, and has established a partnership with Oncobiologics, Inc. for the creation and commercialization of monoclonal antibody products. Viropro Inc. is headquartered in San Jose, California.
株価
$0.00002
最終同期: 2026-08-11
時価総額
$25.40K
変化(1日)
0.00%
変化(1年)
-80.00%
US
取引 Viropro Inc. (VPRO)

カテゴリー

Viropro Inc.(VPRO)の配当利回りの履歴
Viropro Inc.(銘柄コード: VPRO)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Viropro Inc.(VPRO)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)